Search All News
A large clinical trial has found that a minimally invasive procedure to replace a narrowed heart valve performed better than surgery in patients who were good candidates for surgery.
Martin B. Leon, MD, was honored with a Lifetime Achievement Award from the American College of Cardiology for his contributions to the treatment of heart disease with minimally invasive techniques.
Data from an ongoing study found that women who had experienced frequent weight fluctuations had more risk factors for heart disease.
Historically considered a man’s disease, heart disease now claims the lives of more women than men. But symptoms between the sexes can differ, and men and women are treated differently.
- May 26, 2016
Wearing a 24-hour monitoring device may help identify African-Americans who have masked hypertension.
- May 25, 2016
A large study found a positive correlation between traffic-related air pollution and the amount of calcium deposited in the coronary arteries.
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
- May 15, 2016
Lowering blood pressure goals for people with cardiovascular risk factors could save tens of thousands of lives annually and reduce costs.
- April 2, 2016
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.
- February 24, 2016
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a new study from Columbia researchers.
- January 6, 2016
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
- December 9, 2015
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
- December 7, 2015
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.